{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:24:39Z","timestamp":1648891479703},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.neurol.2009.01.051","type":"journal-article","created":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T08:16:47Z","timestamp":1242461807000},"page":"1099-1102","source":"Crossref","is-referenced-by-count":3,"title":["Infarctus c\u00e9r\u00e9bral r\u00e9cidivant r\u00e9v\u00e9lant une maladie de Biermer"],"prefix":"10.1016","volume":"165","author":[{"given":"A.","family":"Bougteba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Basir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kissani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2009.01.051_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archinte.160.4.422","article-title":"Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?","volume":"160","author":"Christien","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.neurol.2009.01.051_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D\u2019Angelo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.neurol.2009.01.051_bib3","first-page":"917","article-title":"Hyperhomocysteinemia, thrombosis and vascular biology","volume":"50","author":"Ebbesen","year":"2004","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.neurol.2009.01.051_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.STR.31.5.1069","article-title":"Association between high homocysteine and ischemic stroke due to large and small-artery disease but not other etiologic subtypes of ischemic stroke","volume":"31","author":"Eikelboom","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2009.01.051_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2009.01.051_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh023","article-title":"Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction","volume":"127","author":"Hassan","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.01.051_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1172\/JCI10588","article-title":"Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model","volume":"107","author":"Hofmann","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2009.01.051_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.59.4.529","article-title":"Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: Results of a meta-analysis","volume":"59","author":"Kelly","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.051_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.161.13.1589","article-title":"Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?","volume":"161","author":"Knekt","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.neurol.2009.01.051_bib10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.STR.30.5.974","article-title":"Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke","volume":"30","author":"Kristensen","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2009.01.051_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0035-3787(06)75112-8","article-title":"L\u2019accident isch\u00e9mique c\u00e9r\u00e9bral, une complication rare de la maladie de Biermer","volume":"162","author":"Leemann","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2009.01.051_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","article-title":"Mechanisms of homocysteine-induced atherothrombosis","volume":"3","author":"Lentz","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neurol.2009.01.051_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.revmed.2004.03.008","article-title":"Donn\u00e9es actuelles sur la maladie de Biermer. \u00c0 propos d\u2019une \u00e9tude r\u00e9trospective de 49 observations","volume":"25","author":"Loukili","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.neurol.2009.01.051_bib14","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arterosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurol.2009.01.051_bib15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/01.CIR.99.18.2383","article-title":"Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)","volume":"99","author":"McQuillan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.neurol.2009.01.051_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20000188","article-title":"Homocysteine and thiol metabolites in vitamin B12 deficiency","volume":"100","author":"Ranganath","year":"2001","journal-title":"Clin Sci"},{"key":"10.1016\/j.neurol.2009.01.051_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(04)00826-9","article-title":"Homocysteine, B-vitamin supplementation, and stroke prevention: from observationnal to interventional trials","volume":"3","author":"Schwammenthal","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2009.01.051_bib18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM199711133372007","article-title":"Pernicious anemia","volume":"337","author":"Toh","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.01.051_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. The vitamin intervention for stroke prevention (VISP). Randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2009.01.051_bib20","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.CIR.96.8.2542","article-title":"Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans","volume":"96","author":"Woo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.neurol.2009.01.051_bib21","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.29.12.2478","article-title":"Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis","volume":"29","author":"Yoo","year":"1998","journal-title":"Stroke"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T07:53:15Z","timestamp":1589788395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378709001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0035378709001775"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2009.01.051","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}